BETRFOTCPharmaceutical PreparationsFiscal year ends January 31

BetterLife Pharma Inc.

Financials through fiscal 2026, year ended Jan 31, 2026Last filing: 20-F on Jun 1, 2026

$0.15−0.01 (-3.71%)

Close on Oct 19, 2026

Market cap: $22.36M
P/E (TTM): –
Dividend yield: –

BetterLife Pharma Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-01-31	FY 2025 2025-01-31	FY 2024 2024-01-31	FY 2023 2023-01-31	FY 2022 2022-01-31	FY 2021 2021-01-31	FY 2020 2020-01-31	FY 2019 2019-01-31	FY 2018 2018-01-31	FY 2017 2017-01-31	FY 2016 2016-01-31	FY 2015 2015-01-31	FY 2014 2014-01-31	FY 2013 2013-01-31	FY 2012 2012-01-31	FY 2011 2011-01-31	FY 2010 2010-01-31	FY 2009 2009-01-31
Research & Development	–	–	–	–	–	–	–	–	0.07	–	–	–	–	–	0.06	–	–	–
General & Administrative	–	–	–	–	–	–	–	–	0.34	1.60	7.70	0.03	–	0.02	0.07	0.06	–	–
Operating Expenses	–	–	–	–	–	–	–	–	1.05	6.02	10	0.12	–	–	–	–	–	–
Operating Income	–	–	–	–	–	–	–	–	-1.05	-6.02	-10	-0.12	–	–	–	–	–	–
Interest Expense	–	–	–	–	–	–	–	–	0.03	0.01	–	0.06	–	-0.02	-0.06	–	–	–
Other Non-Operating Income	–	–	–	–	–	–	–	–	–	–	–	–	–	0.43	1.78	-2.88	–	–
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	-0.09	-0.36	-0.14	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	-6.44	-9.79	-0.98	–	0.34	1.42	-3.02	-0.12	-0.65
Net Income	–	–	–	–	–	–	–	–	-0.12	-6.28	-10	-1.13	–	0.34	1.42	-3.02	–	–
Net Income to Common	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00	0.00	0.00	–	–
EPS (Basic)(per share)	–	–	–	–	–	–	–	–	0.00	-0.08	-0.13	-0.10	–	–	–	–	–	–
EPS (Diluted)(per share)	–	–	–	–	–	–	–	–	0.00	-0.08	-0.13	-0.10	–	–	–	–	–	–
Shares Outstanding (Basic, Weighted)(shares)	146	124	109	87	75	27	15	9.02	80	75	78	12	4.83	3.58	3.39	2.80	–	–
Shares Outstanding (Diluted, Weighted)(shares)	146	124	109	87	0.44	0	0	90	80	75	78	12	4.83	3.58	3.39	2.80	–	–
EBITDA	–	–	–	–	–	–	–	–	–	–	-10	-0.12	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jan 31, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2026: –

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –